Unknown

Dataset Information

0

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via ?-Catenin-Mediated Nuclear Translocation.


ABSTRACT: The membrane glycoprotein CD200 binds to its receptor CD200R1 and induces tolerance, mainly in cells of the myeloid lineage; however, information regarding its role in solid tumors is limited. Here, we investigated whether CD200 expression, which is enriched mainly in high-grade head and neck squamous cell carcinoma (HNSCC), correlates with cancer progression, particularly the epithelial-to-mesenchymal transition (EMT). The forced overexpression of CD200 in the HNSCC cell line, UMSCC84, not only increased the expression of EMT-related genes, but also enhanced invasiveness. The cleaved cytoplasmic domain of CD200 interacted with ?-catenin in the cytosol, was translocated to the nucleus, and eventually enhanced EMT-related gene expression. CD200 increased the invasiveness of mouse tonsillar epithelium immortalized with E6, E7, and Ras (MEER), a model of tonsillar squamous cell carcinoma. siRNA inhibition of CD200 or extracellular domain of CD200R1 down-regulated the expression of EMT-related genes and decreased invasiveness. Consistently, compared to CD200-null MEER tumors, subcutaneous CD200-expressing MEER tumors showed significantly increased metastatic migration into draining lymph nodes. Our study demonstrates a novel and unique role of CD200 in inducing EMT, suggesting the potential therapeutic target for blocking solid cancer progression.

SUBMITTER: Shin SP 

PROVIDER: S-EPMC6826410 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation.

Shin Seung-Phil SP   Goh A-Ra AR   Kang Hyeon-Gu HG   Kim Seok-Jun SJ   Kim Jong-Kwang JK   Kim Kyung-Tae KT   Lee John H JH   Bae Yong-Soo YS   Jung Yuh-Seog YS   Lee Sang-Jin SJ  

Cancers 20191017 10


The membrane glycoprotein CD200 binds to its receptor CD200R1 and induces tolerance, mainly in cells of the myeloid lineage; however, information regarding its role in solid tumors is limited. Here, we investigated whether CD200 expression, which is enriched mainly in high-grade head and neck squamous cell carcinoma (HNSCC), correlates with cancer progression, particularly the epithelial-to-mesenchymal transition (EMT). The forced overexpression of CD200 in the HNSCC cell line, UMSCC84, not only  ...[more]

Similar Datasets

| S-EPMC8234594 | biostudies-literature
| S-EPMC8582421 | biostudies-literature
| S-EPMC6959035 | biostudies-literature
| S-EPMC6171749 | biostudies-literature
| S-EPMC8173099 | biostudies-literature
| S-EPMC6205178 | biostudies-literature
| S-EPMC3029362 | biostudies-literature
| S-EPMC4941285 | biostudies-literature
| S-EPMC4731626 | biostudies-literature
| S-EPMC5095019 | biostudies-literature